119 related articles for article (PubMed ID: 17476464)
1. Evaluation of enhanced peritoneum permeability in methylglyoxal-treated rats as a diagnostic method for peritoneal damage.
Fumoto S; Nakashima Y; Nishida K; Kodama Y; Nishi J; Nakashima M; Sasaki H; Otsuka N; Nakamura J
Pharm Res; 2007 Oct; 24(10):1891-6. PubMed ID: 17476464
[TBL] [Abstract][Full Text] [Related]
2. Novel diagnostic method of peritoneal injury using dual macromolecular markers.
Hirata H; Miyamoto H; Shimokawa K; Nakashima M; Nakayama M; Fumoto S; Nishida K
Biol Pharm Bull; 2014; 37(2):262-7. PubMed ID: 24492723
[TBL] [Abstract][Full Text] [Related]
3. Absorption of phenol red and bromphenol blue as model drugs from the peritoneal cavity around the liver surface in rats.
Nishida K; Amagishi H; Sasaki H; Nakamura J
J Pharm Pharmacol; 1995 Dec; 47(12A):1032-5. PubMed ID: 8932690
[TBL] [Abstract][Full Text] [Related]
4. Absorption of phenolsulfonphthalein as a model across the mesenteric surface in rats to determine the drug absorption route after intraperitoneal administration.
Nishida K; Nose S; Kuma A; Mukai T; Nakashima M; Sasaki H; Nakamura J
J Pharm Pharmacol; 2004 May; 56(5):683-7. PubMed ID: 15142348
[TBL] [Abstract][Full Text] [Related]
5. Evaluation for Peritoneal Injury at an Early Stage Using Dual Macromolecular Markers.
Hirata H; Fumoto S; Miyamoto H; Nakashima M; Nakayama M; Nishida K
Biol Pharm Bull; 2016; 39(10):1581-1587. PubMed ID: 27725434
[TBL] [Abstract][Full Text] [Related]
6. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
[TBL] [Abstract][Full Text] [Related]
7. Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in Mice.
Nagai T; Doi S; Nakashima A; Irifuku T; Sasaki K; Ueno T; Masaki T
PLoS One; 2016; 11(8):e0160993. PubMed ID: 27513960
[TBL] [Abstract][Full Text] [Related]
8. Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.
Hirahara I; Ishibashi Y; Kaname S; Kusano E; Fujita T
Nephrol Dial Transplant; 2009 Feb; 24(2):437-47. PubMed ID: 18790810
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal fibrosis induced by intraperitoneal methylglyoxal injection: the role of concurrent renal dysfunction.
Onishi A; Akimoto T; Morishita Y; Hirahara I; Inoue M; Kusano E; Nagata D
Am J Nephrol; 2014; 40(4):381-90. PubMed ID: 25358632
[TBL] [Abstract][Full Text] [Related]
10. Hypermetabolism of glutathione, glutamate and ornithine via redox imbalance in methylglyoxal-induced peritoneal injury rats.
Hirahara I; Kusano E; Jin D; Takai S
J Biochem; 2020 Feb; 167(2):185-194. PubMed ID: 31593282
[TBL] [Abstract][Full Text] [Related]
11. Absorption characteristics of model compounds with different molecular weights from the serosal caecal surface in rats.
Nishida K; Nose S; Kuma A; Mukai T; Kawakami S; Nakashima M; Sasaki H; Sakaeda T; Nakamura J
J Pharm Pharmacol; 2002 Jul; 54(7):1005-9. PubMed ID: 12162704
[TBL] [Abstract][Full Text] [Related]
12. Hyper-vascular change and formation of advanced glycation endproducts in the peritoneum caused by methylglyoxal and the effect of an anti-oxidant, sodium sulfite.
Nakayama M; Sakai A; Numata M; Hosoya T
Am J Nephrol; 2003; 23(6):390-4. PubMed ID: 14551463
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin gallate suppresses peritoneal fibrosis in mice.
Kitamura M; Nishino T; Obata Y; Furusu A; Hishikawa Y; Koji T; Kohno S
Chem Biol Interact; 2012 Jan; 195(1):95-104. PubMed ID: 22101032
[TBL] [Abstract][Full Text] [Related]
14. Effect of intestinal atrophy and hepatic impairment induced by parenteral nutrition on drug absorption and disposition in rats.
Fukushima K; Miki T; Nakamoto K; Nishimura A; Koyama H; Ichikawa H; Shibata N; Tokuyama S; Sugioka N
JPEN J Parenter Enteral Nutr; 2015 Feb; 39(2):218-27. PubMed ID: 23894177
[TBL] [Abstract][Full Text] [Related]
15. Effect of selective cyclooxygenase-2 inhibitor lumiracoxib on phenolsulfonphthalein disposition in rats.
Honjo H; Uwai Y; Nabekura T
Drug Metabol Drug Interact; 2014; 29(3):203-6. PubMed ID: 24870608
[TBL] [Abstract][Full Text] [Related]
16. DNA microarray analysis of the epithelial-mesenchymal transition of mesothelial cells in a rat model of peritoneal dialysis.
Imai T; Hirahara I; Morishita Y; Onishi A; Inoue M; Muto S; Kusano E
Adv Perit Dial; 2011; 27():11-5. PubMed ID: 22073821
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic analysis of the absorption enhancing action of decanoic acid and its derivatives in rats.
Takahashi K; Murakami T; Kamata A; Yumoto R; Higashi Y; Yata N
Pharm Res; 1994 Mar; 11(3):388-92. PubMed ID: 8008704
[TBL] [Abstract][Full Text] [Related]
18. Assessing the permeability of the gastrointestinal mucosa after oral administration of phenolsulfonphthalein.
Toh Y; Korenaga D; Maekawa S; Matsumata T; Muto Y; Ikeda T; Sugimachi K
Hepatogastroenterology; 1997; 44(16):1147-51. PubMed ID: 9261615
[TBL] [Abstract][Full Text] [Related]
19. Influence of liver disease on phenolsulfonphthalein absorption from liver surface to examine possibility of direct liver surface application for drug targeting.
Nishida K; Honda T; Nakashima M; Sasaki H; Nakamura J
Biol Pharm Bull; 2003 Jul; 26(7):988-93. PubMed ID: 12843624
[TBL] [Abstract][Full Text] [Related]
20. Role of adhesion molecules in the progression of peritoneal sclerosis.
Imai H; Nakamoto H; Fukushima R; Ishida Y; Yamanouchi Y; Suzuki H
Adv Perit Dial; 2003; 19():180-5. PubMed ID: 14763058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
